Connection
Christopher Nitkin to Bevacizumab
This is a "connection" page, showing publications Christopher Nitkin has written about Bevacizumab.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.435 |
|
|
|
-
Nitkin CR, Richardson T, Lewis T. Is Anti-Vascular Growth Factor Therapy for Retinopathy of Prematurity Associated With Pulmonary Hypertension?-Reply. JAMA Ophthalmol. 2023 04 01; 141(4):408-409.
Score: 0.221
-
Nitkin CR, Bamat NA, Lagatta J, DeMauro SB, Lee HC, Patel RM, King B, Slaughter JL, Campbell JP, Richardson T, Lewis T. Pulmonary Hypertension in Preterm Infants Treated With Laser vs Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity. JAMA Ophthalmol. 2022 11 01; 140(11):1085-1094.
Score: 0.215